Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

MEDI-0639 shows preliminary evidence of antitumor activity

July 6, 2015

Phase I study shows promising results for GS-5745 in patients with advanced solid tumors

July 6, 2015

Ajinomoto divulges AJS-1669 for type 2 diabetes

July 3, 2015

Preclinical and first-in-human data of BI-655064 as a CD40 inhibitor

July 3, 2015

First-in-human clear images of glioblastoma patients using [18F]AA-7

July 3, 2015

Novartis reports phase I results for INC-280 plus erlotinib

July 3, 2015

New ultra-long-acting insulin analogue with improved PK/PD profile

July 3, 2015

CD-133-targeted oncolytic adenovirus therapy shows promising preclinical results

July 3, 2015

First-in-human results presented for LY-3023414

July 3, 2015

Prolong's novel ANF compound for hematopoiesis deficiencies

July 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...